Your browser is no longer supported. Please, upgrade your browser.
OREX Orexigen Therapeutics, Inc. monthly Stock Chart
OREX [NASD]
Orexigen Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.40 Insider Own34.03% Shs Outstand145.43M Perf Week-10.87%
Market Cap238.51M Forward P/E- EPS next Y-0.33 Insider Trans0.00% Shs Float144.53M Perf Month7.19%
Income-50.30M PEG- EPS next Q-0.08 Inst Own78.30% Short Float16.34% Perf Quarter-39.71%
Sales42.50M P/S5.61 EPS this Y60.00% Inst Trans-9.11% Short Ratio9.97 Perf Half Y-51.62%
Book/sh0.36 P/B4.56 EPS next Y34.00% ROA-23.40% Target Price5.25 Perf Year-69.91%
Cash/sh1.61 P/C1.02 EPS next 5Y- ROE-262.10% 52W Range1.39 - 9.37 Perf YTD-4.65%
Dividend- P/FCF4.76 EPS past 5Y28.10% ROI-28.80% 52W High-82.50% Beta2.44
Dividend %- Quick Ratio6.80 Sales past 5Y253.90% Gross Margin- 52W Low17.99% ATR0.15
Employees47 Current Ratio7.10 Sales Q/Q-67.60% Oper. Margin- RSI (14)43.22 Volatility9.21% 9.57%
OptionableYes Debt/Eq1.88 EPS Q/Q-200.00% Profit Margin- Rel Volume0.36 Prev Close1.65
ShortableYes LT Debt/Eq1.88 EarningsFeb 25 BMO Payout- Avg Volume2.37M Price1.64
Recom2.40 SMA20-8.30% SMA50-9.01% SMA200-49.69% Volume862,192 Change-0.61%
Dec-11-15Resumed BofA/Merrill Underperform
Dec-04-15Downgrade Wells Fargo Outperform → Market Perform
Nov-06-15Reiterated RBC Capital Mkts Outperform $9 → $5
Oct-06-15Reiterated Piper Jaffray Overweight $21 → $11
Mar-27-15Reiterated RBC Capital Mkts Outperform $10 → $14
Jan-23-15Initiated RBC Capital Mkts Outperform $10
Jan-10-14Initiated WallachBeth Buy $9
Oct-03-13Initiated Cowen Outperform $10
Sep-21-11Upgrade JMP Securities Mkt Perform → Mkt Outperform $5
Feb-01-11Downgrade JMP Securities Mkt Outperform → Mkt Perform
Feb-01-11Downgrade Canaccord Genuity Buy → Hold
Dec-03-10Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform
Jul-16-10Reiterated JMP Securities Mkt Outperform $16 → $13
Jul-16-10Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
Feb-02-10Initiated Jefferies & Co Buy $12
Jun-24-09Initiated Rodman & Renshaw Mkt Outperform $14
Mar-13-09Reiterated Lazard Capital Mkts Buy $13 → $10
Apr-03-08Initiated Cowen & Co Outperform
Feb-06-08Initiated Lazard Capital Buy
Feb-04-08Reiterated Canaccord Adams Buy $29 → $32
Feb-09-16 10:23AM  Here's Why Arena Pharmaceuticals Lost 17% of Its Value in January at Motley Fool -7.47%
Feb-08-16 04:26PM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers -5.43%
Feb-04-16 08:32AM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure +5.59%
Feb-02-16 04:15PM  Orexigen Therapeutics to Speak at Upcoming Investor Conferences PR Newswire
Jan-30-16 01:01PM  Biotech's Dumbest CEO Moves in 2015 at Motley Fool
Jan-25-16 01:31PM  Some cheap biotech stocks that could be buyout targets, RBC says at MarketWatch -5.73%
12:25PM  Why Zafgen Inc's Stock Is in the Red Today at Motley Fool
Jan-24-16 07:51AM  3 Stocks I Would Avoid at All Costs at Motley Fool
Jan-22-16 07:14AM  8 Stocks Under $10 Making Big Moves Higher at TheStreet
Jan-12-16 09:30AM  Orexigen Targets Profitability by 2018, Focus on Contrave
Jan-11-16 08:37AM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:30AM  Orexigen announces 2016 financial outlook and key priorities PR Newswire
Jan-08-16 04:17PM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
04:15PM  Orexigen Therapeutics names Thomas Lynch as EVP, General Counsel & Secretary and Heather Ace as EVP, Global Human Resources PR Newswire
12:48PM  Blame This for Orexigen Therapeutics, Inc.'s Mind-Numbingly Bad 2015 at Motley Fool
Jan-07-16 12:04PM  Arena Pharmaceuticals Ends 2015 On a Sour Note: Can It Recover in 2016? at Motley Fool -6.29%
Jan-05-16 04:01PM  Orexigen Therapeutics to Speak at the J.P. Morgan 2016 Global Healthcare Conference PR Newswire
Dec-29-15 08:22AM  10 Biotechs Short Sellers Are Betting Against
Dec-28-15 01:02PM  The Worst Biotech Stocks in 2015 at Motley Fool
Dec-22-15 09:46AM  Orexigen Therapeutics, Inc. Earnings Analysis: Q3, 2015 By the Numbers
Dec-17-15 04:12PM  How Martin Shkreli Allegedly Created a Ponzi Scheme With Biotech Stocks at Fortune +7.50%
Dec-08-15 01:17PM  OREXIGEN THERAPEUTICS, INC. Financials
01:12PM  Orexigen Therapeutics' Stock Dropped 28% in November: Can It Recover? at Motley Fool
Dec-07-15 09:45AM  INVESTOR ALERT: 4 Stocks Under $10 With Increased Volatility Accesswire -5.94%
Dec-04-15 04:57PM  Orexigen Therapeutics, Inc.'s Stock Loses Weight on Downgrade at Motley Fool -8.60%
04:32PM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial St
Dec-02-15 05:32PM  What Do Hedge Funds Think of Orexigen Therapeutics, Inc. (OREX)? at Insider Monkey
03:20PM  Zafgen Plunges On Death In Obesity-Drug Trial at Investor's Business Daily
Dec-01-15 11:06AM  Here's Why Arena Pharmaceuticals' Stock Briefly Spiked Today at Motley Fool
Nov-30-15 02:33PM  Is Model N Inc (MODN) A Good Stock To Buy? at Insider Monkey
Nov-25-15 05:35PM  Drugmakers drop weight
09:00AM  Orexigen Therapeutics to Speak at the Piper Jaffray 27th Annual Healthcare Conference PR Newswire
Nov-24-15 04:02PM  Is Marine Products Corp. (MPX) A Good Stock To Buy? at Insider Monkey
08:15AM  Direction of Market Influences - Research on Orexigen, Cara Therapeutics, Uniqure and Baozun Accesswire
Nov-18-15 01:14PM  Value Investing in BioPharma
Nov-16-15 07:45AM  Looking into the Price Movements - Research on Agenus, Straight Path, Orexigen Therapeutics and Cara Therapeutics Accesswire
Nov-11-15 07:03AM  A Competitor's Pain Proves to Be Orexigen Therapeutics' Gain in October at Motley Fool
Nov-09-15 06:29AM  OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
Nov-06-15 04:01PM  Orexigen Therapeutics to Present at Credit Suisse 2015 Healthcare Conference PR Newswire -16.25%
02:35PM  Orexigen Q3 Loss Narrower-Than-Expected, Revenues Top
12:20PM  Why Orexigen Therapeutics, Inc.'s Stock Is Losing Weight Today at Motley Fool
Nov-05-15 10:15PM  Edited Transcript of OREX earnings conference call or presentation 5-Nov-15 10:00pm GMT
05:53PM  Orexigen reports 3Q loss
05:00PM  Orexigen Therapeutics Inc Earnings Call scheduled for 5:00 pm ET today
04:19PM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosu
04:01PM  Orexigen Therapeutics Reports Financial and Business Results for the Third Quarter Ended September 30, 2015 PR Newswire
07:07AM  Q3 2015 Orexigen Therapeutics Inc Earnings Release - After Market Close
Nov-04-15 08:40AM  Technical Review of Stocks from Diverse Sectors - Research on Orexigen Therapeutics, Teligent, Tetraphase Pharmaceuticals and A10 Networks Accesswire
Nov-03-15 09:00AM  Orexigen Announces Naltrexone/Bupropion Data Presentations at ObesityWeek 2015 PR Newswire
Nov-02-15 07:04AM  3 Things You Never Knew About Medicare at Motley Fool +9.21%
Oct-30-15 12:25PM  Here's Why Arena Pharmaceuticals, Inc. Is Struggling Today at Motley Fool
08:19AM  Why biotech could be on the verge of a rebound
Oct-24-15 02:04PM  The Bottom Ten Stocks of XBI Outperform on October 8
Oct-22-15 04:15PM  Orexigen Therapeutics to Provide Business Update and Discuss Third Quarter 2015 Financial Results on November 5, 2015 PR Newswire
Oct-21-15 09:30AM  These Five Biotech Stocks Ranked Among This UK-based Funds Favorites at Insider Monkey
Oct-18-15 10:38AM  3 Biotech Stocks We're Ready to Sell at Motley Fool
Oct-16-15 12:23PM  Why Zafgen Plummeted Today at Motley Fool +6.71%
Oct-13-15 12:41PM  Orexigen Therapeutics Inc. (OREX) and Spectranetics Corp (SPNC): Billionaires Klarman and Cohen Snapped Up These Healthcare Stocks at Insider Monkey -5.53%
Oct-11-15 09:32PM  Trending Now: OREX
09:01AM  Here's Why Orexigen Therapeutics' Stock Tanked in September at Motley Fool
Oct-09-15 05:53PM  After-Hours Moves Led By Orexigen Therapeutics, EMC, Clean Energy Fuels And Cadiz +6.30%
Oct-05-15 06:13AM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
Oct-03-15 09:03AM  Forget Big Pharma: These Little Stocks Offer Far Richer Investing Opportunities at Motley Fool
Oct-01-15 11:02AM  Orexigen Therapeutics, Inc. Earnings Q2, 2015
08:45AM  Orexigen Announces Submission of Contrave┬« New Drug Application in South Korea PR Newswire
Sep-25-15 05:53PM  5 Sell-Ranked Biotechs That Fell More Than 5% Today -7.14%
Sep-24-15 05:00PM  Orexigen Receives $22M Milestone Payment for Contrave -7.44%
Sep-23-15 09:50AM  Orexigen Therapeutics Receives $15 Million Milestone Payment
08:30AM  Orexigen Receives Payments Totaling $22 Million from U.S. and Korean Partners PR Newswire
Sep-18-15 09:21PM  Why Hasn't Orexigen Launched Its Obesity Drug in Europe Yet? at Motley Fool
Sep-16-15 10:58AM  5 Healthcare Stocks Under $10 Ready To Pop at Insider Monkey
10:25AM  Mid-Morning Market Update: Markets Mixed; FedEx Earnings Miss Estimates
Sep-10-15 11:48AM  Here's Why Orexigen Therapeutics' Stock Briefly Spiked Today at Motley Fool +9.92%
11:43AM  You Should Follow Hedge Funds Into One Semiconductor and One Healthcare Stock at Insider Monkey
11:30AM  Orexigen Therapeutics (OREX) Stock Climbs on $60 Million Investment at TheStreet
10:14AM  Mid-Morning Market Update: Markets Mostly Flat; Krispy Kreme Misses Q2 Estimates
09:24AM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equi
09:18AM  Orexigen Raises $60 Million in Sale of Common Stock to Baupost PR Newswire
Sep-06-15 07:04AM  Here's What Caused Orexigen Therapeutics to Slim Down in August at Motley Fool
Sep-04-15 09:00AM  Orexigen Therapeutics to Speak at the Wells Fargo Securities 2015 Healthcare Conference PR Newswire
Aug-21-15 04:07PM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
02:02PM  How the bulls are playing Orexigen
Aug-09-15 08:13PM  10-Q for Orexigen Therapeutics, Inc. at Company Spotlight
Aug-07-15 07:05PM  OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report -10.79%
06:15PM  Orexigen 2Q Loss Wider Than Expected, Settles with Takeda - Analyst Blog
Aug-06-15 01:10PM  Edited Transcript of OREX earnings conference call or presentation 6-Aug-15 12:00pm GMT +9.16%
01:04PM  Why Orexigen Therapeutics' Stock Rocketed Higher at Motley Fool
08:00AM  Orexigen Therapeutics Inc Earnings Call scheduled for 8:00 am ET today
07:45AM  Orexigen reports 2Q loss
07:09AM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and
07:07AM  Q2 2015 Orexigen Therapeutics Inc Earnings Release - Before Market Open
07:00AM  Orexigen Therapeutics Reports Financial and Business Results for the Second Quarter Ended June 30, 2015 PR Newswire
06:59AM  Orexigen Announces Korean Distributorship Agreement with Kwang Dong Pharmaceutical Company PR Newswire
06:58AM  Orexigen and Takeda Announce an Amended and Restated Collaboration Agreement PR Newswire
Aug-05-15 07:17AM  Why Orexigen Therapeutics Inc Stock Fell 18% in July at Motley Fool
Jul-24-15 08:00AM  Orexigen Therapeutics to Provide Business Update and Discuss Second Quarter 2015 Financial Results on August 6, 2015 PR Newswire +9.69%
Jul-05-15 02:18PM  Obesity Statistics Take a Wrong Turn in This Latest Study at Motley Fool
Jun-26-15 04:51PM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
Jun-18-15 09:00AM  Orexigen Therapeutics to Speak at the JMP Securities Life Sciences Conference PR Newswire
Jun-11-15 04:07PM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products in the United States. The company offers Contrave for the treatment of obesity. It has a collaboration agreement with Takeda Pharmaceutical Company Limited to develop and commercialize Contrave in Canada and Mexico. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Booth Mark DChief Commercial OfficerFeb 26Option Exercise1.6650,00083,00053,810Mar 02 05:34 PM
Booth Mark DChief Commercial OfficerFeb 26Sale5.6850,000284,2003,810Mar 02 05:34 PM